← Open Payments lookup

GARY GOFF: Open Payments

NPI 1629050521 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,989 in 104 payments from 24 companies in 2025. Trend: 2023 $2,079 · 2024 $1,902 · 2025 $1,989

Food & beverage: $1,989
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP21$374
ABBVIE INC.13$242
Amgen Inc.13$180
PFIZER INC.8$155
Boehringer Ingelheim Pharmaceuticals, Inc.5$102
GlaxoSmithKline, LLC.4$102
Novartis Pharmaceuticals Corporation4$101
Otsuka America Pharmaceutical, Inc.4$98
Insmed, Inc.4$92
Axsome Therapeutics, Inc.4$91

Products named: FARXIGA, OTEZLA, AIRSUPRA, TRELEGY ELLIPTA, REXULTI, Arikayce, Auvelity, QULIPTA.

Industry payments across TX — which companies pay providers there.